Issue Stories

Flow Cytometry Controls

For Beckman Coulter systems

pn11.jpg (12106 bytes)CD-Chex Plus® BC and CD-Chex® Plus BC CD4 Low are new assayed controls for immunophenotyping with Beckman Coulter® flow cytometry systems, including the Coulter® Prep-Plus™. CD-Chex Plus BC verifies the accuracy and reproducibility of all the steps involved in the process of immunophenotyping, including red blood cell lysis. Reference values are established for five subsets of leukocytes: T lymphocytes, B lymphocytes, granulocytes, monocytes, and NK cells. CD-Chex Plus BC CD4 Low offers a depressed CD4 absolute number often found in patients with immunodeficiency diseases. Both products offer a 30-day open-vial stability and a 90-day closed-vial stability and are available in plastic vials with pierceable caps containing 3.0 mL fill. Unlike a fresh whole-blood sample, the stability of CD-Chex Plus BC and CD-Chex Plus BC CD4 Low provide reproducible data when used for daily quality control of immunophenotyping procedures. STATS®, a free interlaboratory quality-control program, is available for qualifying CD-Chex Plus BC customers. STATS produces relevant peer-group comparison reports and graphs with a quick turnaround time. Data can be submitted by mail, fax, or e-mail. The reports include customer data, peer-group averages, and computer-generated Levey-Jennings graphs.

Streck
(800) 843-0912; www.streck.com

|
|

MEDIA CENTER

Interactive Media
Resources
Classifieds
Calendar
Consumer Resources
Media Kit
Advertiser Index
EAB
Reprints

ADDITIONAL ONLINE RESOURCES

Allied Healthcare
Medical Education
24X7mag
Chiropractic Products Magazine
Clinical Lab Products (CLP)
Orthodontic Products
The Hearing Industry Resource
HME Today
Rehab Management
Physical Therapy Products
Plastic Surgery Products
Imaging Economics
Medical Imaging
RT Magazine
Sleep Review
SynerMed Communications
IMED Communications
Practice Growth
Practice Builders
powered by:
Copyright © 2008 Ascend Media LLC | Clinical Lab Products | All Rights Reserved.
Privacy Policy | Terms of Service